Arts Optical International Holdings Limited (HKG:1120)
1.090
-0.010 (-0.91%)
Jan 21, 2026, 2:47 PM HKT
HKG:1120 Revenue
Arts Optical International Holdings had revenue of 594.94M HKD in the half year ending June 30, 2025, with 5.03% growth. This brings the company's revenue in the last twelve months to 1.27B, up 2.80% year-over-year. In the year 2024, Arts Optical International Holdings had annual revenue of 1.28B with 7.19% growth.
Revenue (ttm)
1.27B
Revenue Growth
+2.80%
P/S Ratio
0.33
Revenue / Employee
373.77K
Employees
3,600
Market Cap
424.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.28B | 85.96M | 7.19% |
| Dec 31, 2023 | 1.20B | 52.21M | 4.56% |
| Dec 31, 2022 | 1.14B | -8.84M | -0.77% |
| Dec 31, 2021 | 1.15B | 410.32M | 55.25% |
| Dec 31, 2020 | 742.62M | -298.34M | -28.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |